$7.53 Billion is the total value of Paulson & Co.'s 100 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GLD | SPDR GOLD TRUST | $517,586,000 | +8.3% | 4,359,722 | 0.0% | 6.87% | +14.1% | |
| VRX | VALEANT PHARMACEUTICALS INTL | $213,811,000 | -24.0% | 19,384,500 | 0.0% | 2.84% | -20.0% | |
| CACQ | CAESARS ACQUISITION COcl a | $202,017,000 | +14.1% | 13,117,998 | 0.0% | 2.68% | +20.1% | |
| RLGY | REALOGY HLDGS CORP | $142,545,000 | +15.8% | 4,785,000 | 0.0% | 1.89% | +21.9% | |
| CZR | CAESARS ENTMT CORP | $137,691,000 | +12.4% | 14,417,900 | 0.0% | 1.83% | +18.3% | |
| AU | ANGLOGOLD ASHANTI LTDsponsored adr | $137,666,000 | +2.5% | 12,782,400 | 0.0% | 1.83% | +7.9% | |
| SGYPQ | SYNERGY PHARMACEUTICALS DEL | $112,253,000 | -23.5% | 24,088,655 | 0.0% | 1.49% | -19.4% | |
| BACWSA | BANK OF AMERICA CORPORATION* w exp 01/16/2019 | $70,778,000 | +13.6% | 6,263,526 | 0.0% | 0.94% | +19.6% | |
| WLH | LYON WILLIAM HOMEScl a new | $68,513,000 | +8.4% | 3,322,666 | 0.0% | 0.91% | +14.1% | |
| COBALT INTL ENERGY INCnote 3.125% 5/15/2024 | $54,807,000 | -10.7% | 219,229,000 | 0.0% | 0.73% | -6.1% | ||
| ENZY | ENZYMOTEC LTD | $37,013,000 | +34.4% | 4,205,980 | 0.0% | 0.49% | +41.5% | |
| THM | INTERNATIONAL TOWER HILL MIN | $29,131,000 | -5.8% | 55,487,842 | 0.0% | 0.39% | -0.8% | |
| ALXN | ALEXION PHARMACEUTICALS INCcall | $24,248,000 | -0.9% | 200,000 | 0.0% | 0.32% | +4.5% | |
| IAG | IAMGOLD CORP | $15,456,000 | +3.9% | 3,863,912 | 0.0% | 0.20% | +9.6% | |
| SYMX | SYNTHESIS ENERGY SYS INC | $8,520,000 | -14.8% | 10,000,000 | 0.0% | 0.11% | -10.3% | |
| BACWSB | BANK OF AMERICA CORPORATION* w exp 10/28/2018 | $8,194,000 | -4.4% | 8,928,344 | 0.0% | 0.11% | +0.9% | |
| NSR | NEUSTAR INCcl a | $6,630,000 | -0.7% | 200,000 | 0.0% | 0.09% | +4.8% | |
| KMDA | KAMADA LTD | $4,969,000 | +24.8% | 730,800 | 0.0% | 0.07% | +32.0% | |
| NVDQ | NOVADAQ TECHNOLOGIES INCput | $3,895,000 | +15480.0% | 500,000 | 0.0% | 0.05% | – | |
| BCRX | BIOCRYST PHARMACEUTICALScall | $2,940,000 | +32.7% | 350,000 | 0.0% | 0.04% | +39.3% | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | $1,539,000 | 0.0% | 74,000 | 0.0% | 0.02% | +5.3% | |
| PBYI | PUMA BIOTECHNOLOGY INC | $584,000 | +21.2% | 15,690 | 0.0% | 0.01% | +33.3% | |
| ARDMQ | ARADIGM CORP | $299,000 | -2.9% | 192,727 | 0.0% | 0.00% | 0.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
About Paulson & Co.
Paulson & Co. is a New York-based investment management firm founded by John Paulson in 1994. The firm is known for its expertise in event-driven investing, which involves taking advantage of market inefficiencies created by corporate events such as mergers, acquisitions, bankruptcies, and spin-offs. Paulson & Co. manages approximately $9 billion in assets and has a team of over 100 professionals.
John Paulson, the founder and CEO of Paulson & Co., is a renowned hedge fund manager who made a fortune by betting against the subprime mortgage market in 2007. He is considered one of the most successful investors of his generation, with a net worth of over $4 billion. Paulson is actively involved in the management of the firm and oversees the investment strategy.
Paulson & Co. has a strong track record of generating high returns for its investors. The firm's flagship fund, the Paulson Advantage Fund, has delivered an average annual return of 12.5% since its inception in 1994. The fund has also outperformed the S&P 500 index in 16 out of the past 22 years.
In recent years, Paulson & Co. has faced some challenges, including a decline in assets under management and a series of high-profile losses. However, the firm has remained committed to its investment philosophy and has continued to generate strong returns for its investors. With a talented team of professionals and a proven track record of success, Paulson & Co. is well-positioned to continue delivering value to its clients in the years ahead.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NOVAGOLD RESOURCES INC | 42 | Q3 2023 | 12.0% |
| INTERNATIONAL TOWER HILL MINE | 42 | Q3 2023 | 3.4% |
| IAMGOLD CORP | 42 | Q3 2023 | 0.5% |
| ANGLOGOLD ASHANTI-SPON ADR | 41 | Q2 2023 | 7.9% |
| AGNICO EAGLE MINES LTD | 34 | Q3 2023 | 3.8% |
| SPDR GOLD TRUST | 33 | Q1 2022 | 13.3% |
| TRILOGY METALS INC NEW | 29 | Q3 2023 | 0.9% |
| ENDO INTL PLC | 28 | Q2 2022 | 3.4% |
| CAESARS ENTMT CORP | 27 | Q4 2019 | 4.6% |
| TIM PARTICIPACOES SA-ADR | 26 | Q3 2020 | 2.4% |
View Paulson & Co.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Thryv Holdings, Inc. | February 14, 2023 | 2,000,000 | 5.8% |
| Endo International plc | February 14, 2022 | 17,327,012 | 7.4% |
| BrightSphere Investment Group Inc. | December 22, 2021 | 8,950,121 | 19.8% |
| PERPETUA RESOURCES CORP. | August 27, 2021 | 20,929,280 | 33.3% |
| Bausch Health Companies Inc. | May 15, 2020 | 25,839,035 | 7.3% |
| OVERSEAS SHIPHOLDING GROUP INC | April 13, 2020 | 6,300,000 | 7.3% |
| SYNTHESIS ENERGY SYSTEMS INC | February 14, 2020 | 165,648 | 10.5% |
| Callon Petroleum Co | November 18, 2019 | 10,338,663 | 4.5% |
| International Seaways, Inc. | July 03, 2019 | 1,459,119 | 5.0% |
| AKORN INCSold out | February 14, 2018 | 0 | 0.0% |
View Paulson & Co.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 4 | 2024-01-22 |
| SC 13D/A | 2024-01-22 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
View Paulson & Co.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.